{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-007812","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2022-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.694255+00:00","generated_at":"2026-06-21T09:30:15.409696+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Predictive Oncology appoints Matthew J. Hawryluk, Ph.D. to Board of Directors","bullets":["Appointed as Class II director effective Nov 29, 2022; fills vacancy from J. Melville Engle's retirement.","Currently EVP and Chief Business Officer at Gritstone bio (NASDAQ: GRTS).","Awarded $5,000 in common stock from the Company's 2012 Stock Incentive Plan.","Bringing experience from Foundation Medicine and Thermo Fisher Scientific; Ph.D. in cell biology and MBA.","His term expires at the 2023 annual meeting of stockholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-007812","json":"https://secwatch.observer/filing/0001171843-22-007812.json","markdown":"https://secwatch.observer/filing/0001171843-22-007812.md","text":"https://secwatch.observer/filing/0001171843-22-007812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184322007812/0001171843-22-007812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184322007812/f8k_120222.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T09:30:15.409696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e128561444","claim":"Matthew J. Hawryluk, Ph.D. was elected as Class II director at Axe Compute Inc..","evidence_excerpt":"Effective November 29, 2022, the Board of Directors (“Board”) of Predictive Oncology Inc. (the “Company”) elected Matthew J. Hawryluk, Ph.D., to the Board as a Class II director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184322007812/0001171843-22-007812-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}